prescription drugs

The ruling is likely to be challenged at the United States Court of Appeals for the District of Columbia Circuit.

After two flat years, the medical cost trend is expected to rise in 2020, according to PricewaterhouseCoopers.

Empire State lawmakers are considering legislation that would implement a fee-for-service program and effectively cut out PBMs.

Investment grade pharmaceutical companies continue to display a high capacity for M&A activity, according to a new Moody's report.

A Kaiser Family Foundation report found that 82% of total retail prescription drug spending in 2017 came from private insurers,...

Feds spell out how 'spread pricing' is calculated in medical loss ratios.

Xellia becomes Civica's first supplier partner and will produce antibiotics in short supply in U.S. hospitals.

The final rule will require drug makers to post the list price if that price is equal to or greater...

The four proposed bills share a common goal: avoiding some of the thorny issues around drug pricing and instead getting...

A federal judge reaffirmed his view that the cuts by HHS to the discount drug program are unlawful.

The two companies allegedly used independent foundations to pay Medicare beneficiaries' copays for their own products, an illegal inducement under...

Colleen Lindholz, president of Kroger Health, spoke about the grocery store's plans to expand further into healthcare.